Tested Applications
| Positive WB detected in | HeLa cells, human skeletal muscle tissue |
| Positive IHC detected in | human intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
12939-1-AP targets IFRD1 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag3988 Product name: Recombinant human IFRD1 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-451 aa of BC001272 Sequence: MPKNKKRNTPHRGSSAGGGGSGAAAATAATAGGQHRNVQPFSDEDASIETMSHCSGYSDPSSFAEDGPEVLDEEGTQEDLEYKLKGLIDLTLDKSAKTRQAALEGIKNALASKMLYEFILERRMTLTDSIERCLKKGKSDEQRAAAALASVLCIQLGPGIESEEILKTLGPILKKIICDGSASMQARQTCATCFGVCCFIATDDITELYSTLECLENIFTKSYLKEKDTTVICSTPNTVLHISSLLAWTLLLTICPINEVKKKLEMHFHKLPSLLSCDDVNMRIAAGESLALLFELARGIESDFFYEDMESLTQMLRALATDGNKHRAKVDKRKQRSVFRDVLRAVEERDFPTETIKFGPERMYIDCWVKKHTYDTFKEVLGSGMQYHLQSNEFLRNVFELGPPVMLDAATLKTMKISRFERHLYNSAAFKARTKARSKCRDKRADVGEFF Predict reactive species |
| Full Name | interferon-related developmental regulator 1 |
| Calculated Molecular Weight | 451 aa, 50 kDa |
| Observed Molecular Weight | 51 kDa |
| GenBank Accession Number | BC001272 |
| Gene Symbol | IFRD1 |
| Gene ID (NCBI) | 3475 |
| RRID | AB_10597099 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O00458 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for IFRD1 antibody 12939-1-AP | Download protocol |
| WB protocol for IFRD1 antibody 12939-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The IFRD1 Polyclonal antibody (Cat# 12939-1-AP) has 4 citations across four journals: Science Bulletin, Frontiers in Immunology, RNA Biology, and eLife. Research fields span hepatic metabolism and fatty liver disease, prostate cancer and unfolded protein response, RNA biology involving translation termination and nonsense-mediated decay, and eIF2-mediated translational regulation. Applications cited include Western blotting and immunohistochemistry in human and mouse samples.
| Species | Application | Title |
|---|---|---|
Sci Bull (Beijing) Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axis.
| ||
Front Immunol Multi-omics analyses related to unfolded protein response in prostate cancer implicate pro-tumor role of IFRD1. | ||
RNA Biol Divergent effects of translation termination factor eRF3A and nonsense-mediated mRNA decay factor UPF1 on the expression of uORF carrying mRNAs and ribosome protein genes. | ||







